Stock detail
Uniqure (QURE) stock price, chart, and key data
View Uniqure stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Uniqure
QURE · XNAS
$47.60
+7.01%
+$3.12
Pre-market $44.80 (-5.88%)
Key metrics
Earnings
Past Income Statement
Close price
$44.48
Market cap
$3B
P/E ratio
-13.68
About the company
UNIQURE BV
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app